Increased nitric oxide in exhaled air of patients with systemic lupus erythematosus

Journal of Rheumatology

Volumn 24, Issue 6, 1997, Pages 1066-1071

  Rolla, Giovanni ^a,d   Brussino, Luisa ^a   Bertero, Maria Tiziana ^a,b   Colagrande, Paola ^a   Converso, Marcella ^a   Bucca, Caterina ^a   Polizzi, Salvatore ^a,c   Caligaris Cappio, Federico ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c Dept of Resp and Occup Disease   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

Nitric oxide; Pulmonary function tests; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROXYCHLOROQUINE; METHOTREXATE; NITRIC OXIDE; PREDNISONE;

ADULT; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; LUNG FUNCTION; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BREATH TESTS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NITRIC OXIDE; RESPIRATORY FUNCTION TESTS;

EID: 0030960292     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Schmidt HHW, Walter U: NO at work. Cell 1994;78:918-25.
2. Mills CD: Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J Immunol 1991;146:2719-23.
3. Green IC, Cunningham JM, Delaney CA, Elphik MR, Mabley JG, Green MHL: Effects of cytokines and nitric oxide donors on insulin secretion, cyclic GMP and DNA damage: Relation to nitric oxide production. Biochem Soc Trans 1994;22:30-7.
4. G-monomethyl-L-arginine. J Exp Med 1994;179:651-60.
5. McCartney-Francis N, Allen JB, Mizel DE, et al: Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993;178:749-54.
6. Farrell AJ, Blake DR, Palmer RMJ, Moncada S: Increased concentration of nitrite in synovial fluid and serum samples suggest increased nitic oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219-22.
7. Ueki Y, Miyake S, Tominaga Y, Eguchi K: Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 1996;23:230-6.
8. Persson MG, Zetterstrom O, Agrenius V, Ihre E, Gustafsson LE: Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994;343:146-7.
9. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ: Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994;343:133-5.
10. Wright CD, Mulsch A, Busse R, Osswald H: Generation of nitric oxide by human neutrophils. Biochem Biophys Res Commun 1989,160:813-9.
11. Kobzik L, Bredt DS, Lowenstein CJ, et al: Nitric oxide synthase in human and rat lung: Immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 1993;9:371-7.
12. Busse R, Mülsch A: Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 1990;275:87-90.
13. Asano K, Chee CB, Gaston B, et al: Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci USA 1994;91:10089-93.
14. Grennan DM, Howie AD, Moran F, Buchanan WW: Pulmonary involvement in systemic lupus erythematosus. Ann Rheum Dis 1987;37:536-9.
15. Groen H, Aslander M, Bootsma H, van der Mark ThW, Kallenberg CGM, Postma DS: Bronchoalveolar lavage cell analysis and lung function impairment in patients with systemic lupus erythematosus. Clin Exp Immunol 1993;94:127-33.
16. Rolla G, Brussino L, Bertero MT, Bucca C, Converso M, Caligaris-Cappio F: Respiratory function in systemic lupus erythematosus: Relation with activity and severity. Lupus 1996;5:38-43.
17. Gross M, Esterly JR, Earle RH: Pulmonary alterations in systemic lupus erythematosus. Am Rev Respir Dis 1982;105:572-7.
18. Eisenberg H, Dubois EL, Sherwin RP, Balchum OJ: Diffuse interstitial lung disease in systemic lupus erythematosus. Ann Intern Med 1973;79:37-45.
19. Gordon C, Emery P: Cytokines and the acute phase response in SLE. Lupus 1993;2:345-7.
20. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR: Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 1991;147:117-23.
21. Aderka D, Wysenbeek A, Engelmann H, et al: Correlation between serum levels of soluble tumor necrosis factor and disease activity in systemic lupus erythematosus. Arthritis Rheum 1993;39:1111-20.
22. Meijer C, Huysen V, Smeenk RTJ, Swaak AJG: Profile of cytokines (TNF-α and IL-6) and acute phase proteins (CRP and α1-AG) related to the disease course of patients with systemic lupus erythematosus. Lupus 1993;2:359-65.
23. Tan EM, Cohen AS, Fries JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
24. Vitali C, Bencivelli W, Isenberg DA, et al: Disease activity in systemic lupus erythematosus: Report of the Consensus Study Group of the European Workshop for Rheumatology Research. Clin Exp Rheumatol 1992;10:541-7.
25. American Thoracic Society Executive Committee: Recommended standardized procedures for pulmonary testing. Am Rev Respir Dis 1978;118:55-72.
26. Quanjer PhH, ed. Standardized lung function testing. Bull Europ Physiopath Respir 1983;(suppl 5)19:45-51.
27. American Thoracic Society: Single breath carbon monoxide diffusing capacity (transfer factor): Recommendation for a standard technique - 1995 Update. Am J Respir Crit Care Med 1995;152:2185-98.
28. Cotes JE: Measurement of the transfer factor (diffusing capacity) for the lung and its subdivisions. In: Cotes JE, ed. Lung Function. Assessment and Application in Medicine, 4th ed. Oxford: Blackwell Scientific, 1979:230-50.
29. Gerlach H, Rossaint R, Pappert D, Knorr M, Falke KJ: Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx: Lancet 1994;343:518-9.
30. Kharitonov SA, Chung KF, Evans D, O'Connor BJ, Barnes PJ: Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med 1996;153:1773-80.
31. Kharitonov SA, Wells AV, O'Connor BJ, Hansell DM, Cole PJ, Barnes PJ: Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med 1995;151:1889-93.
32. Kharitonov SA, Yates D, Barnes PJ: Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J 1995;8:295-7.
33. Andonopoulos AP, Constantopoulos SH, Galanopoulos V, Drosos AA, Acritidis NC, Moutsopoulos HM: Pulmonary function of nonsmoking patients with systemic lupus erythematosus. Chest 1955;94:312-5.
34. Eichacker PQ, Pinsker K, Epstein A, Schiffenbauer J, Grayzel A: Serial pulmonary function testing in patients with systemic lupus erythematosus. Chest 1988;94:129-32.
35. Cerveri I, Fanfulla F, Ravelli A, et al: Pulmonary function in children with systemic lupus erythematosus. Thorax 1996;51:424-8.
36. Matsumoto A, Ogura K, Hirata Y, et al: Increased nitric oxide in the exhaled air of patients with decompensated liver cirrhosis. Ann Intern Med 1995;123:110-3.
37. Tilg H, Wilmer A, Vogel W, Herold M, Nölchen B, Judmaier G: Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264-74.
38. Stewart TE, Valenza F, Ribeiro SP, et al: Increased nitric oxide in exhaled gas as an early marker of lung inflammation in a model of sepsis. Am J Respir Crit Care Med 1995;151:713-8.
39. Maury CPJ, Teppo AM: Tumor necrosis factor in the serum of patients with systemic lupus erythematosus. Arthritis Rheum 1989;32:146-50.
40. Massaro AF, Gaston B, Kita D, Fanta C, Stamler JS, Drazen JM: Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995;152:800-3.
41. Kharitonov SA, Yates DH, Chung KF, Barnes PJ: Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 1996;9:196-201.
42. Hamid Q, Springall DR, Riveros-Moreno V, et al: Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510-3.